Clinical Benefit of Antisense Therapy in a Phase III Trial in Patients With CLL
Cancer Biology and Therapy - United States
doi 10.4161/cbt.6.3.4165
Full Text
Open PDFAbstract
Available in full text
Date
March 1, 2007
Authors
Unknown
Publisher
Informa UK Limited